Ranolazine Global Buyers List: A Complete Guide for Suppliers and Exporters
Ranolazine is a piperazine derivative approved for the treatment of chronic angina pectoris. It works by inhibiting the late sodium current in cardiac myocytes, reducing intracellular sodium and calcium overload, and thereby decreasing myocardial oxygen demand while improving exercise tolerance. As the global demand for cardiovascular therapeutics continues to rise, identifying reliable ranolazine buyers has become a strategic priority for API manufacturers, exporters, and distributors.
This guide provides a comprehensive overview of the ranolazine global buyers landscape, covering key buyer countries, importer categories, trade data insights, and regulatory considerations. It also outlines practical strategies for connecting with verified ranolazine buyers and building sustainable business relationships.
Understanding the Ranolazine Market Landscape
The global ranolazine market encompasses both the active pharmaceutical ingredient (API) and finished dosage forms, primarily extended-release tablets. The market is segmented by application into preinfarction angina and post-infarction angina, with purity grades typically divided between 98% and greater than 98%.
Key players in the ranolazine manufacturing and supply chain include JSN Chemicals, Jubilant Pharma, Cemex Pharma, Precise Chemipharma, Nuray Chemicals, SVK Laboratories, Ind-Swift Laboratories, Wuhai Fulin Bio-Technology, Srini Lakshmi Life Science, and Cambrex. These companies form the upstream segment of the supply chain, supplying API to formulators and generic drug manufacturers worldwide.
Top Ranolazine Buyer Countries
Trade data analysis reveals that ranolazine imports are concentrated across several key markets. According to import shipment records, the top ten ranolazine buyer countries are Pakistan, the United States, India, Bangladesh, Turkey, Singapore, the United Kingdom, Sri Lanka, China, and Russia. Singapore leads in total import shipments, followed by the United Kingdom and the United States.
Bangladesh has emerged as a significant buyer of ranolazine from India, with exports valued at approximately US $70.8 thousand in a single quarter. Pakistan follows closely as a major destination for Indian ranolazine exports. These figures underscore the importance of South Asian markets as primary buyers of ranolazine finished dosage forms.
Categories of Ranolazine Buyers
Ranolazine buyers can be categorized into several distinct groups, each with unique sourcing requirements and regulatory expectations.
Finished Dosage Form Importers and Distributors purchase ranolazine extended-release tablets for distribution within their domestic markets. Companies such as Lifestar Pharma LLC in the United States import ranolazine ER tablets in both 500 mg and 1000 mg strengths from Indian manufacturers. Similarly, M/S Pharma Associates in Sri Lanka imports ranolazine extended-release tablets from India.
Generic Pharmaceutical Manufacturers acquire ranolazine API to produce their own finished dosage forms. These buyers typically require API that complies with United States Pharmacopeia (USP), European Pharmacopoeia (EP), or British Pharmacopoeia (BP) standards, along with comprehensive regulatory documentation including Drug Master Files (DMFs) and Certificates of Suitability (CEPs).
Contract Manufacturing Organizations (CDMOs) and research institutions also purchase ranolazine API for formulation development, analytical method validation, and abbreviated new drug application (ANDA) preparation.
Trade Data and HSN Codes for Ranolazine
Ranolazine trade is classified under specific Harmonized System Nomenclature (HSN) codes that vary by product form. Finished ranolazine extended-release tablets typically fall under HSN code 30049079, while ranolazine API is classified under HSN code 29420090.
Trade intelligence platforms such as Volza track ranolazine import and export shipments across over 93 countries. The data captures shipment quantities, declared values, origin and destination countries, and specific buyer and supplier profiles. This information is invaluable for suppliers seeking to identify active buyers, understand pricing dynamics, and target high-potential markets.
Regulatory Requirements for Ranolazine Buyers
Regulatory compliance is a critical consideration for ranolazine buyers and suppliers alike. Manufacturers seeking to supply ranolazine API to the United States market must file a Drug Master File (DMF) with the Food and Drug Administration (FDA). As of recent regulatory filings, there are 19 manufacturers with active filings, 18 of which hold a US DMF.
In the European Union, suppliers must obtain a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines. The availability of these regulatory credentials significantly influences buyer decisions, as pharmaceutical importers prioritize suppliers with validated compliance histories and successful regulatory inspections.
How to Find and Connect with Ranolazine Buyers
Identifying and connecting with qualified ranolazine buyers requires a multi-channel approach that combines trade data intelligence, industry networking, and targeted outreach.
Leverage Trade Data Platforms such as Volza, which maintain comprehensive databases of ranolazine importers and their shipment histories. These platforms enable suppliers to filter buyers by country, import volume, product specification, and purchasing frequency.
Participate in Pharmaceutical Trade Exhibitions including CPHI, BioPharma Asia, and regional pharma expos. These events provide direct access to procurement managers and decision-makers from importing companies across the globe.
Build Regulatory Credentials by obtaining DMF filings and GMP certifications from recognized authorities. Buyers increasingly verify supplier credentials through regulatory databases before initiating commercial discussions.
Develop a Digital Presence through optimized company profiles on B2B platforms, pharmaceutical sourcing portals, and professional networks. Case studies, product specifications, and regulatory documentation should be readily accessible to potential buyers.
Key Ranolazine API Manufacturers and Suppliers
For buyers seeking reliable ranolazine API sources, the supplier landscape includes established manufacturers with demonstrated capabilities in complex organic synthesis and regulatory compliance.
CordenPharma, Lonza, and WuXi AppTec are prominent CDMOs with ranolazine API manufacturing capabilities. Divi’s Laboratories, an India-based producer, is recognized for large-scale manufacturing capacity and cost-effectiveness. Granules India Ltd. has also established itself as a key supplier of ranolazine API, with a notable presence in the Indian market.
Additional API manufacturers include Apis Laboratories, Huahai Pharmaceutical, SUANFARMA, SMS Pharmaceuticals, Dr. Reddy’s Laboratories, Aarti Industries, Hangzhou Longshine Bio-Tech, and Qingyun Pharmaceutical. These companies collectively form a robust global supply network capable of meeting diverse buyer requirements.
Market Trends and Future Outlook
The ranolazine market is projected to experience steady growth, driven by the rising global prevalence of cardiovascular diseases and the expanding use of ranolazine in chronic angina management. Emerging markets in South Asia, the Middle East, and Latin America present significant opportunities for suppliers, as healthcare infrastructure improvements and increased access to generic pharmaceuticals drive demand.
Trade data indicates that ranolazine imports are growing across multiple regions. Suppliers who proactively engage with buyers in these emerging markets, while maintaining regulatory compliance and competitive pricing, are well-positioned to capture a growing share of the global ranolazine trade.
CAMBER PHARMACEUTICALS INC
TABROS PHARMA PVT LTD
HIGHNOON LABORATORIES LIMITED
A MENARINI PHILIPPINES INC
AXIA PVT LTD
ASCEND LABORATORIES LLC
NIPPON EXPRESS USA INC
PROPHARMEX INDIA PRIVATE LIMITED
SCIEGEN PHARMACEUTICALS INC
A MENARINI LATIN AMERICA S L U SUCURSAL DEL PERU
GENETICS PHARMACEUTICALS PRIVATE LIMITED
ULTRA INTERNATIONAL
WORLD MEDICINE ILAC SANAYI VE TICARET ANONIM SIRKETI
A MENARINI MEXICO SA DE CV
SQUARE PHARMACEUTICALS PLC CHANGED
POPULAR PHARMACEUTICALS PLC
EXPEDITORS INTL OF WA INC
INCEPTA PHARMACEUTICALS LIMITED
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
MSN LABS PERU S A C
UMEDICA LABORATORIES PRIVATE LIMITED
ALI RAIF ILAC SANAYI ANONIM SIRKETI
AZELIS TR KIMYA ENDUSTRISI URUNLERI ITHALAT IHRACAT TICARET VE SANAYI ANONIM SIRKETI
GENETICS PHARMACEUTICALS PVT LTD
HIGHNOON LABORATORIES LTD
M S MAPLE PHARMACEUTICALS PVT LTD
MENARINI ILAC SANAYI VE TICARET ANONIM SIRKETI
OOO FARM LYUKS INVEST
ООО CURATIO PHARM
CHI NHÁNH CTY TNHH ZUELLIG PHARMA VIỆT NAM
RENATA PLC CHANGED FROM RENATA
SIMBA PHARMACEUTICALS LIMITED
SUN PHARMACEUTICALS EZ LIMITED
THE SEARLE COMPANY LIMITED
TOKYO CHEMICAL INDUSTRY INDIA PRIVATE LIMITED
UNICHEM PHARMACEUTICALS USA INC
ASAP LOGISTICS LTD
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
INTAS PHARMACEUTICALS LIMITED
LIFESTAR PHARMA LLC
M G PHARMACEUTICALS LIMITED
OOO GRAND PHARM TRADE
SUN PHARMACEUTICAL INDUSTRIES LIMITED
TABROS PHARMA PRIVATE LIMITED
YUSEN LOGISTICS AMERICAS INC
АКЦІОНЕРНЕ ТОВАРИСТВО ФАРМАК 04080 М КИЇВ ВУЛ КИРИЛІВСЬКА 63
ООО БЕРЛИН ХЕМИ А МЕНАРИНИ
CAVALIER LOGISTICS
ESKAYEF PHARMACEUTICALS LIMITED
GENERAL PHARMACEUTICALS LTD
I3 PHARMACEUTICALS LLC
UNISON PHARMACEUTICALS PRIVATE LIMITED
VIONA PHARMACEUTICALS INC
АТ ФАРМАК УКРАЇНА 04080 М КИЇВ ВУЛ КИРИЛІВСЬКА 63
AUROLOGISTICS LLC
GRAND CORPORATION PVT LTD
HC LEGD GROUP S A C
HORIZON HEALTHCARE PVT LTD
JSC MEROS PHARM
LLC MEROS PHARM
RENATA LTD CHANGE FROM PFIZER
SOFTCARE IN L PVT LTD
SUN PHARMACEUTICAL BANGLADESH
UNICHEM LABORATORIES LIMITED
BIO MARK PHARMACEUTICALS
EVEREST PHARMACEUTICALS LIMITED
GLOBELINE INTERNATIONAL SHIPPING IN
HORIZON HEALTHCARE PRIVATE LIMITED
HORIZON HEALTHCARE RIVATE LIMITED
M S HIGHNOON LABORATORIES LTD
MAPLE PHARMACEUTICALS PVT LTD
MEDREICH LIMITED
MENAFAR SOCIEDAD ANONIMA
MEROS PHARM
NIPPON EXPRESS U S A INC
OPSONIN PHARMA LIMITED
SMS PHARMACEUTICALS LIMITED
STADA PHILIPPINES INC
TECHSTREAM CORPORATION LTD
A MENARINI LATIN AMERICA S L U SUC COLOMBIA
ADVANCED CHEMICAL INDUSTRIES LTD
ADVANCED CHEMICAL INDUSTRIES PLC
ASOCIACION VIDA PERU
AUROBINDO PHARMA LTD
AXIA PHARMACEUTICALS PVT LTD
AZ GEMS INC
DRUG INTERNATIONAL LIMITED
DRUGLAND CORPORATION
F A R LOGISTICS INC
GLENMARK PHARMACEUTICALS INC USA
GLENMARK PHARMACEUTICALS LIMITED
HELBA ILAC IC VE DIS SANAYI TICARET ANONIM SIRKETI
JET LOGISTICS GROUP CORPORATION LIMITED
LAMBDA THERAPEUTIC RESEARCH LIMITED
LLC GRAND PHARM TRADE
MEDSCRIBE LIMITED
NEWGEN LANKA HEALTH CARE PVT LTD
NON COMMERCIAL IMPORTER
OOO ASTOR ALLIANCE
OOO MEROS PHARM
SAMINAZ AND COMPANY PVT LTD
SIGMA ALDRICH QUIMICA S DE RL DE CV
SKYLINE FREIGHT INC
STATE INSTITUTION CENTER FOR PHARMACEUTICAL PRODUCT SAFETY
ИП ООО NOBEL PHARMSANOAT
ООО GRAND PHARM TRADE
ООО MEROS PHARM
A J WORLDWIDE SERVICES INC
A MENARINI MEXICO SERVICIOS SA DE CV
AJANTA PHARMA LIMITED
ALCHEM ENTERPRISE
ASPIN PHARMA PVT LIMITED
ASPIN PHARMA PVT LTD
ASTOR ALLIANCE
AUROBINDO PHARMA USA INC
BAJWA PHARMACEUTICALS PVT LIMITED
BLUPAX PHARMACEUTICALS
BROWN BURK PHILIPPINES INC
CHEM EXPERTZ LIMITED
CHROMATO SCIENTIFIC PRIVATE LIMITED
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
DHL PAKISTAN PRIVATE LIMITED
EMCURE PHARMA PERU SOCIEDAD ANONIMA CERRADA
EVERON LIFE SCIENCES
GENETICS PHARMACEUTICAL PVT LTD
GENOME PHARMACEUTICALS PVT LIMITED
GENOME PHARMACEUTICALS PVT LTD
GERRY S INTERNATIONAL PRIVATE LIMITED
GLENMARK PHARMACEUTICALS INC US
GLOBAL PHARMACEUTICALS PVT LIMITED
GLOBAL PHARMACEUTICALS PVT LTD
GLOBELINE INTERNATIONAL SHIPPING
HEALTHCARE PHARMACEUTICALS LTD
ISHTIAQ AHMED
JAVED CHEMICAL CORPORATION
KHALID RAFIQ C O TUBASUM
KRKA D D NOVO MESTO
LABORATORY SCIENTIFIC SUPPLIES PRIVATE LIMITED
LLC BERLIN CHEMIE A MENARINI
LLC CURATIO PHARM
M S GENETICS PHARMACEUTICALS
M S GENETICS PHARMACEUTICALS PVT LTD
M S HORIZON HEALTHCARE PVT LTD
M S WNSFEILD PHARMACEUTICALS
MAPLE PHARMACUETICALS PVT LIMITED
MATA AMRITANANDAMAYI MATH
MERCK ALLYRISE INTERNATIONAL
MICRO NOVA PHARAMACEUTICALS INDLTD
MOHEB IRSHAD LTD
NIPPON EXPRESS USA INC SAVANNAH
NOBEL ILAC SANAYII VE TICARET ANONIM SIRKETI
NOVAMED PHARMACEUTICALS PVT LIMITED
O HERVANARIO S DE RL
OOCL LOGISTICS LINE LIMITED
PHARMASOL PRIVATE LTD
PHARMASOL PVT LTD
PIRAMAL PHARMA LIMITED
PJSC FARMAK
POPULAR PHARMACEUTICALS LTD
PT DEXA MEDICA
RED INNOVATION SOCIEDAD ANONIMA
S HIGHNOON LABORATORIES LIMITED
SANDS ACTIVE PRIVATE LIMITED
STATE PHARMACEUTICALS CORPORARION
SURYA PHARMA LIMITED
THE CHEMICALS
THE IBN SINA PHARMACEUTICAL
THE SEARLE COMPANY LTD
TORRENT PHARMA INC
TRADE MARKET 57 SA DE CV
UNITED STATES PHARMACOPEIA INDIA PRIVATE LIMITED
WILSHIRE LABORATRIES PRIVATE LIMITED
WILSHIRE LABS PVT LTD
WNSFEILD PHARMACEUTICALS
YADEN INTERNATIONAL PVT LTD
АТ ФАРМАК 04080 УКРАЇНА М КИЇВ ВУЛ КИРИЛІВСЬКА БУД 63
ГУ ЦЕНТР БЕЗОПАСНОСТИ ФАРМАЦЕВТИЧЕСКОЙ ПРОДУКЦИИ
МЧЖ MEROS PHARM
ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ ІНЕСЕНЛАБС УКРАЇНА 07302 КИЇВСЬКА ОБЛ ВИШГОРОДСЬКИЙ Р Н МІСТО ВИШГОРОД ВУЛ
Conclusion
Navigating the ranolazine global buyers landscape requires a combination of market intelligence, regulatory diligence, and strategic relationship-building. By understanding the key buyer countries, recognizing the distinct needs of different buyer categories, and leveraging trade data platforms effectively, suppliers and exporters can identify high-value opportunities and establish lasting partnerships with ranolazine buyers worldwide.
For businesses looking to expand their ranolazine trade operations, the path forward involves continuous market monitoring, investment in regulatory credentials, and proactive engagement with the global pharmaceutical procurement community.
